• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型长链4-取代哌嗪衍生物作为5-HT₁A和5-HT₇受体配体的合成及结合特性

Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.

作者信息

Modica Maria N, Intagliata Sebastiano, Pittalà Valeria, Salerno Loredana, Siracusa Maria A, Cagnotto Alfredo, Salmona Mario, Romeo Giuseppe

机构信息

Dipartimento di Scienze del Farmaco, Università di Catania, viale A. Doria 6, Catania 95125, Italy.

Dipartimento di Scienze del Farmaco, Università di Catania, viale A. Doria 6, Catania 95125, Italy.

出版信息

Bioorg Med Chem Lett. 2015 Apr 1;25(7):1427-30. doi: 10.1016/j.bmcl.2015.02.042. Epub 2015 Feb 25.

DOI:10.1016/j.bmcl.2015.02.042
PMID:25759032
Abstract

New long-chain 4-substituted piperazines linked to a thienopyrimidine or a quinazoline system were synthesized and tested for their binding properties on human cloned 5-HT1A and 5-HT7 serotonin receptors. Some structural modifications, concerning tree main portions, that is, terminal fragment, chain length, and aryl substituents, were examined. The 2- and 3-substituted thienopyrimidinone and quinazolinone systems were selected as terminal fragment and a chain length of four or five methylene units was set. Explored aryl substituents were phenyl, phenylmethyl, 3- or 4-chlorophenyl, and 2-ethoxyphenyl. Title compounds showed affinity for 5-HT1A and 5-HT7 receptors. In particular, 2-ethoxyphenyl derivatives 40 and 45 displayed Ki values in the nanomolar range on both receptors, acting as dual ligands.

摘要

合成了与噻吩并嘧啶或喹唑啉系统相连的新型长链4-取代哌嗪,并测试了它们对人克隆的5-HT1A和5-HT7血清素受体的结合特性。研究了关于三个主要部分,即末端片段、链长和芳基取代基的一些结构修饰。选择2-和3-取代的噻吩并嘧啶酮和喹唑啉酮系统作为末端片段,并设定了四个或五个亚甲基单元的链长。探索的芳基取代基有苯基、苯甲基、3-或4-氯苯基以及2-乙氧基苯基。标题化合物对5-HT1A和5-HT7受体表现出亲和力。特别是,2-乙氧基苯基衍生物40和45在两种受体上均显示出纳摩尔范围内的Ki值,作为双重配体起作用。

相似文献

1
Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.新型长链4-取代哌嗪衍生物作为5-HT₁A和5-HT₇受体配体的合成及结合特性
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1427-30. doi: 10.1016/j.bmcl.2015.02.042. Epub 2015 Feb 25.
2
New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT and 5-HT receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies.新型N-和O-芳基哌嗪基烷基嘧啶及2-甲基喹唑啉衍生物作为5-羟色胺和5-羟色胺受体配体:合成、构效关系及分子模拟研究
Bioorg Med Chem. 2017 Feb 1;25(3):1250-1259. doi: 10.1016/j.bmc.2016.12.039. Epub 2016 Dec 27.
3
Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.以环状氨基酸酰胺片段为 5-HT(7) 和 5-HT(1A) 受体配体的长链芳基哌嗪衍生物的固相合成、分子建模和生物活性。
Eur J Med Chem. 2014 May 6;78:10-22. doi: 10.1016/j.ejmech.2014.03.005. Epub 2014 Mar 5.
4
1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.1-芳基-4-(4-琥珀酰亚胺丁基)哌嗪及其构象受限类似物:合成、与5-羟色胺(5-HT1A、5-HT2A、5-HT7)、α1-肾上腺素能和多巴胺能D2受体的结合以及体内5-HT1A功能特性
Bioorg Med Chem. 2005 Mar 15;13(6):2293-303. doi: 10.1016/j.bmc.2004.12.041.
5
New arylpiperazines with flexible versus partly constrained linker as serotonin 5-HT(1A)/5-HT(7) receptor ligands.新型芳基哌嗪类化合物作为 5-羟色胺 5-HT(1A)/5-HT(7) 受体配体,具有柔性连接子和部分约束连接子。
Arch Pharm (Weinheim). 2013 May;346(5):339-48. doi: 10.1002/ardp.201300011. Epub 2013 Apr 22.
6
Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.新型均二和杂二哌嗪基-1-丙酮衍生物作为对5-HT1AR具有选择性的5-HT7R配体的设计与合成。
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4052-6. doi: 10.1016/j.bmcl.2016.06.080. Epub 2016 Jun 28.
7
Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.4-[2-(3-甲氧基苯基)乙基]-1-(2-甲氧基苯基)哌嗪的二价配体方法:5-HT(7)和5-HT(1A)受体的合成及结合亲和力
Bioorg Med Chem. 2007 Aug 1;15(15):5316-21. doi: 10.1016/j.bmc.2007.05.010. Epub 2007 May 6.
8
New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.新型西格玛和5-羟色胺1A受体配体:ω-(四氢萘-1-基)-N-烷基胺衍生物
J Med Chem. 1996 Jan 5;39(1):176-82. doi: 10.1021/jm950409c.
9
Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.新型5-羟色胺7受体激动剂N-(1,2,3,4-四氢萘-1-基)-4-芳基-1-哌嗪烷基酰胺的构效关系研究
J Med Chem. 2004 Dec 16;47(26):6616-24. doi: 10.1021/jm049702f.
10
New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.含降冰片烯核的新型5-羟色胺(1A)受体配体:合成与体外药理学评价
J Med Chem. 2005 Aug 25;48(17):5495-503. doi: 10.1021/jm050246k.

引用本文的文献

1
Pharmaceutical Studies on Piperazine-based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters.针对5-羟色胺受体和5-羟色胺再摄取转运体的哌嗪类化合物的药学研究
Mini Rev Med Chem. 2025;25(1):58-75. doi: 10.2174/0113895575319878240612070850.
2
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease.阿尔茨海默病的当前药物治疗与多靶点治疗方法
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1560. doi: 10.3390/ph15121560.
3
Design Strategies, Chemistry and Therapeutic Insights of Multi-target Directed Ligands as Antidepressant Agents.
多靶点导向配体作为抗抑郁药的设计策略、化学和治疗学见解。
Curr Neuropharmacol. 2022;20(7):1329-1358. doi: 10.2174/1570159X19666211102154311.
4
From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.从杂合子到新支架:阿尔茨海默病多靶标导向配体的最新药物化学目标。
Curr Neuropharmacol. 2021;19(6):832-867. doi: 10.2174/1570159X18666200914155951.
5
Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists.作为 5-HT1A 受体部分激动剂的 1H-咪唑并[2,1-f]嘌呤-2,4(3H,8H)-二酮衍生物的抗抑郁样活性和安全性评价。
PLoS One. 2020 Aug 7;15(8):e0237196. doi: 10.1371/journal.pone.0237196. eCollection 2020.